Diffusion Tensor Metrics as Biomarkers in Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Although diffusion tensor imaging has been a major research focus for Alzheimer's disease in recent years, it remains unclear whether it has sufficient stability to have biomarker potential. To date, frequently inconsistent results have been reported, though lack of standardisation in acquisition and analysis make such discrepancies difficult to interpret. There is also, at present, little knowledge of how the biometric properties of diffusion tensor imaging might evolve in the course of Alzheimer's disease. METHODS: The biomarker question was addressed in this study by adopting a standardised protocol both for the whole brain (tract-based spatial statistics), and for a region of interest: the midline corpus callosum. In order to study the evolution of tensor changes, cross-sectional data from very mild (N = 21) and mild (N = 22) Alzheimer's disease patients were examined as well as a longitudinal cohort (N = 16) that had been rescanned at 12 months. FINDINGS AND SIGNIFICANCE: The results revealed that increased axial and mean diffusivity are the first abnormalities to occur and that the first region to develop such significant differences was mesial parietal/splenial white matter; these metrics, however, remained relatively static with advancing disease indicating they are suitable as 'state-specific' markers. In contrast, increased radial diffusivity, and therefore decreased fractional anisotropy-though less detectable early-became increasingly abnormal with disease progression, and, in the splenium of the corpus callosum, correlated significantly with dementia severity; these metrics therefore appear 'stage-specific' and would be ideal for monitoring disease progression. In addition, the cross-sectional and longitudinal analyses showed that the progressive abnormalities in radial diffusivity and fractional anisotropy always occurred in areas that had first shown an increase in axial and mean diffusivity. Given that the former two metrics correlate with dementia severity, but the latter two did not, it would appear that increased axial diffusivity represents an upstream event that precedes neuronal loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other
Mann, H. B., & Whitney, D. R. (1947) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177730491 · Cited by 14,320
SMITH, S., & NICHOLS, T. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.061 · Cited by 5,250
On the Kolmogorov-Smirnov Test for Normality with Mean and Variance Unknown
Lilliefors, H. W. (1967) · Journal of the American Statistical Association · doi:10.2307/2283970 · Cited by 4,530
Mioshi, E., Dawson, K., Mitchell, J., Arnold, R., & Hodges, J. R. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1610 · Cited by 2,016 · cited 15×
“To address the research questions posed in this study, we first collapsed all DTI measurements from all Alzheimer’s disease subjects (N= 43), which, for each callosal subregion, were crosssectionally compared against control data (N=26) and regressed against a measure of global cognitive status (ACE-R scores).”
MethodInfluentialWITELSON, S. F. (1989) · Brain · doi:10.1093/brain/112.3.799 · Cited by 1,424
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404 · cited 1×
“To date, most biomarker work with magnetic resonance imaging (MRI) has focused on structural acquisitions to measure atrophy [1].”
BackgroundInflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
Wyss-Coray, T., & Rogers, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006346 · Cited by 975 · cited 1×
“The role of inflammatory change in Alzheimer’s disease is presently of considerable interest [41] and it is at least conceivable, given that l1 increase appears to represent something other than axonal loss, that it could be driven by factors such as microglial activation.”
BackgroundAbout “axial” and “radial” diffusivities
Wheeler‐Kingshott, C. A. M., & Cercignani, M. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21965 · Cited by 885 · cited 1×
“A final technical point to note is that although it is discouraged to interpret primary diffusivities on the basis of the underlying neurobiological processes [46], the negligible effects of: (i) crossing fibres, (ii) partial volume–due to lack of atrophy–and (iii) eigenvector sorting bias–due to the large differences…”
BackgroundJack, C. R., Twomey, C. K., Zinsmeister, A. R., Sharbrough, F. W., Petersen, R. C., & Cascino, G. D. (1989) · Radiology · doi:10.1148/radiology.172.2.2748838 · Cited by 592 · cited 1×
“Each measurement was normalised for differences in total intracranial volume using an analysis of covariance approach, where the measured areas were adjusted by an amount proportional to the difference between each individual’s observed total intracranial volume and the global total intracranial volume mean for all co…”
Method
Cited by
Brain atrophy in Alzheimer’s Disease and aging
Pini, L., Pievani, M., Bocchetta, M., Altomare, D., Bosco, P., Cavedo, E., Galluzzi, S., Marizzoni, M., & Frisoni, G. B. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.01.002 · Cited by 836
Effectiveness of regional DTI measures in distinguishing Alzheimer’s disease, MCI, and normal aging
Nir, T. M., Jahanshad, N., Villalon-Reina, J. E., Toga, A. W., Jack, C. R., Weiner, M. W., & Thompson, P. M. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.07.006 · Cited by 348
“Recent longitudinal and cross-sectional studies suggest that AxD might be more sensitive to detecting early changes, while RD becomes progressively better as disease progresses (O'Dwyer et al., 2011; Acosta-Cabronero et al., 2012).”
Diffusion tensor MRI as a biomarker in axonal and myelin damage
Aung, W. Y., Mar, S., & Benzinger, T. L. (2013) · Imaging in Medicine · doi:10.2217/iim.13.49 · Cited by 348
Brain connectivity in neurodegenerative diseases—from phenotype to proteinopathy
Pievani, M., Filippini, N., van den Heuvel, M. P., Cappa, S. F., & Frisoni, G. B. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.178 · Cited by 310
In Vivo Quantitative Susceptibility Mapping (QSM) in Alzheimer's Disease
Acosta-Cabronero, J., Williams, G. B., Cardenas-Blanco, A., Arnold, R. J., Lupson, V., & Nestor, P. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081093 · Cited by 287
Self-citationAmlien, I. K., & Fjell, A. M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.02.017 · Cited by 219
Dyrba, M., Grothe, M., Kirste, T., & Teipel, S. J. (2015) · Human Brain Mapping · doi:10.1002/hbm.22759 · Cited by 187
“, 1992], imaging studies have revealed alterations in DTI-derived measures in AD dementia patients or even prodromal AD stages compared to healthy controls (HC) [Acosta-Cabronero et al., 2012; Agosta et al., 2011; Bozzali, 2002; Canu et al., 2010; Cui et al., 2012; Dyrba et al., 2013; Haller et al., 2010; Medina et al…”
BackgroundResultWhite matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease
Araque Caballero, M. Á., Suárez-Calvet, M., Duering, M., Franzmeier, N., Benzinger, T., Fagan, A. M., Bateman, R. J., Jack, C. R., Levin, J., Dichgans, M., et al. (2018) · Brain · doi:10.1093/brain/awy229 · Cited by 184
White matter hyperintensity topography in Alzheimer's disease and links to cognition
Garnier‐Crussard, A., Bougacha, S., Wirth, M., Dautricourt, S., Sherif, S., Landeau, B., Gonneaud, J., De Flores, R., de la Sayette, V., Vivien, D., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12410 · Cited by 170
Diffusion-MRI in neurodegenerative disorders
Goveas, J., O’Dwyer, L., Mascalchi, M., Cosottini, M., Diciotti, S., De Santis, S., Passamonti, L., Tessa, C., Toschi, N., & Giannelli, M. (2015) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2015.04.006 · Cited by 104
ApoE influences regional white-matter axonal density loss in Alzheimer's disease
Slattery, C. F., Zhang, J., Paterson, R. W., Foulkes, A. J. M., Carton, A., Macpherson, K., Mancini, L., Thomas, D. L., Modat, M., Toussaint, N., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.04.021 · Cited by 102
“In patients with LOAD, fractional anisotropy in the corpus callosum has been shown to correlate with performance on the MMSE (Canu et al., 2013), and more specifically, radial diffusivity and fractional anisotropy in the splenium correlate with dementia severity on the ACE-R (Acosta-Cabronero et al., 2012).”
Lam, B. Y. K., Halliday, G. M., Irish, M., Hodges, J. R., & Piguet, O. (2014) · Human Brain Mapping · doi:10.1002/hbm.22420 · Cited by 90
White matter degeneration in subjective cognitive decline: a diffusion tensor imaging study
Li, X.-Y., Tang, Z.-C., Sun, Y., Tian, J., Liu, Z.-Y., & Han, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.10091 · Cited by 65
“Thus, FA may be useful for monitoring AD progression [35, 36].”
Imaging the accumulation and suppression of tau pathology using multiparametric MRI
Holmes, H. E., Colgan, N., Ismail, O., Ma, D., Powell, N. M., O'Callaghan, J. M., Harrison, I. F., Johnson, R. A., Murray, T. K., Ahmed, Z., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.12.001 · Cited by 51
Whittaker, H. T., Zhu, S., Di Curzio, D. L., Buist, R., Li, X.-M., Noy, S., Wiseman, F. K., Thiessen, J. D., & Martin, M. (2018) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2018.03.010 · Cited by 12
Le Bihan, D. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1858655 · Cited by 1
40 Years of diffusion MRI in the brain: From history to emerging frontiers
Le Bihan, D. (2026) · Imaging Neuroscience · doi:10.1162/imag.a.1365
“…diffusivity measures may be more sensitive than fractional anisotropy, whereas increasing radial diffusivity and declining fractional anisotropy may better track disease severity longitudinally ( Acosta-Cabronero et al., 2010, 2012; Chen et al., 2023; Fu et al., 2014; Lo Buono et al., 2020).”
Metadata
- Authors
- Acosta-Cabronero, J., Alley, S., Williams, G. B., Pengas, G., & Nestor, P. J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-11-07
- Volume
- 7
- Issue
- 11
- Pages
- e49072
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2059412836
- Cited by
- 129
- References
- 17
- FWCI
- 6.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.